MAT Biopharma To Enter In A Research Collaboration With AlgoNomics

Evry, France and Ghent, Belgium - June 12, 2006 - MAT Biopharma SA and AlgoNomics NV today announced they entered into a research collaboration. AlgoNomics will employ its structural bioinformatics platform to assist MAT Biopharma in its research related to the structural analysis of its antibody leads. The research collaboration focused on increasing the structural insight and potential immunogenicity of antibodies against hematological cancer and some solid cancers. Financial terms of the collaboration and the therapeutic focus of the collaboration were not disclosed.